Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment

No abstract is available for this paper.

• Publication year

  2018

• Venue

  American Journal of Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ajg.2017.245PMID 28809383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The gut microbiome and irritable bowel syndrome

  2018cited by this paper
• Update on Dietary Management of Childhood Functional Abdominal Pain Disorders.

  2018cited by this paper
• Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders

  2017cited by this paper
• Adding glucose to food and solutions to enhance fructose absorption is not effective in preventing fructose‐induced functional gastrointestinal symptoms: randomised controlled trials in patients with fructose malabsorption

  2017cited by this paper
• Re‐challenging FODMAPs: the low FODMAP diet phase two

  2017cited by this paper
• A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D

  2016cited by this paper
• Irritable Bowel Syndrome: A Clinical Review.

  2016cited by this paper
• Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut

  2016cited by this paper
• Bowel Disorders.

  2016cited by this paper
• Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome

  2016cited by this paper
• FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

  2016cited by this paper
• Does oral α-galactosidase relieve irritable bowel symptoms?

  2016cited by this paper
• Intestinal Gas Capsules: A Proof-of-Concept Demonstration.

  2016cited by this paper
• Irritable bowel syndrome: a clinical review.

  2015cited by this paper
• A pilot trial on subjects with lactose and/or oligosaccharides intolerance treated with a fixed mixture of pure and enteric-coated α- and β-galactosidase

  2015cited by this paper
• Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.

  2015cited by this paper
• Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome

  2014cited by this paper
• Diets that differ in their FODMAP content alter the colonic luminal microenvironment

  2014cited by this paper
• Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.

  2014cited by this paper
• A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.

  2014cited by this paper
• Design of Clinical Trials Evaluating Dietary Interventions in Patients With Functional Gastrointestinal Disorders

  2013cited by this paper
• Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium

  2013cited by this paper
• Further Validation of the Visual Analogue Scale for Irritable Bowel Syndrome After Use in Clinical Practice

  2013cited by this paper
• The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study

  2013cited by this paper
• Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial

  2013cited by this paper
• Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI

  2013cited by this paper
• Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

  2012cited by this paper
• Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?

  2011cited by this paper
• Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals.

  2011cited by this paper
• A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults.

  2010cited by this paper
• Pancreatic enzyme replacement therapy in chronic pancreatitis.

  2010cited by this paper
• Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index.

  2010cited by this paper
• Dietary poorly absorbed, short‐chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon

  2010cited by this paper
• Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

  2010cited by this paper
• Misreporting of energy and micronutrient intake estimated by food records and 24 hour recalls, control and adjustment methods in practice

  2009cited by this paper
• Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC).

  2009cited by this paper
• In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose.

  2009cited by this paper
• The effects of butyrate enemas on visceral perception in healthy volunteers

  2009cited by this paper
• Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

  2009cited by this paper
• An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome

  2008cited by this paper
• Beneficial effects of oral tilactase on patients with hypolactasia

  2008cited by this paper
• Fructan and free fructose content of common Australian vegetables and fruit.

  2007cited by this paper
• The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms.

  2007cited by this paper
• The Effect of Oral α-Galactosidase on Intestinal Gas Production and Gas-Related Symptoms

  2006cited by this paper
• Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.

  2005cited by this paper
• Personal view: food for thought – western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis

  2005cited by this paper
• Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three‐way crossover study

  2005cited by this paper
• The effect of keeping food records on eating patterns.

  1998cited by this paper
• Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans.

  1997cited by this paper
• Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin.

  1995cited by this paper
• Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance.

  1994cited by this paper
• Comparative effects of exogenous lactase (β-galactosidase) preparations onin vivo lactose digestion

  1993cited by this paper
• Bowel disorders.

  1990cited by this paper
• Effects of Administration of Galactooligosaccharides on the Human Faecal Microflora, Stool Weight and Abdominal Sensation

  1990cited by this paper

• Multi‐environment evaluation of raffinose‐family oligosaccharide content in diverse dry bean varieties and their reduction upon canning

  2025cites this paper
• Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024.

  2025cites this paper
• Tratamiento farmacológico del síndrome de intestino irritable en México. Posicionamiento de la Asociación Mexicana de Gastroenterología 2024

  2025cites this paper
• Gastrointestinal Symptoms and Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Sources in Schoolchildren—A Pilot Study

  2024cites this paper
• A Multi-Digestive Enzyme and Herbal Dietary Supplement Reduces Bloating in a Single Use in Healthy Adults: A Randomized, Placebo-Controlled, Cross Over Study

  2024cites this paper
• Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome

  2024cites this paper
• Evolution, adaptation, and new applications of the FODMAP diet

  2024cites this paper
• Purification, characterisation and immobilisation of a protease‐resistant α‐galactosidase from Monascus purpureus and its application in removal of raffinose family oligosaccharides

  2024cites this paper
• Innovative concepts in diet therapies in disorders of gut–brain interaction

  2024cites this paper
• Safety and Tolerability of Microbial Inulinase Supplementation in Healthy Adults: A Randomized, Placebo-Controlled Trial

  2024cites this paper
• Systematic review and meta-analysis of habitual intake of fermentable oligo-, di-, mono- saccharides and polyols in the general population and revisiting the low FODMAP diet concept

  2024cites this paper
• Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry disease

  2023cites this paper
• Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions

  2023cites this paper
• Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

  2023cites this paper
• Biopharmaceutical applications of α‐galactosidases

  2022cites this paper
• Irritable bowel syndrome

  2022cites this paper
• Fabry disease – a multisystemic disease with gastrointestinal manifestations

  2022cites this paper
• Effect of oat or rice flour on pulse-induced gastrointestinal symptoms and breath hydrogen in subjects sensitive to pulses and controls – a randomised cross-over trial with two parallel groups

  2022cites this paper
• Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia

  2022cites this paper
• Application of The FODMAP Diet in a Paediatric Setting

  2022cites this paper
• How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice

  2022cites this paper
• Low-FODMAP-Diät – Lösung aller Probleme?

  2021cites this paper
• Diagnosis and Management of Gluten-Associated Disorders: A Clinical Casebook

  2021cites this paper
• A randomized double‐blind placebo‐controlled crossover pilot study: Acute effects of the enzyme α‐galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients

  2021cites this paper
• Investigation of different dietary-fibre-ingredients for the design of a fibre enriched bread formulation low in FODMAPs based on wheat starch and vital gluten

  2021cites this paper
• Reply: The key to success: Targeting enzymes to their dietary counterpart

  2021cites this paper
• The key to success: Targeting enzymes to their dietary counterpart

  2021cites this paper
• The Dietitian Role in Non-Celiac Gluten Sensitivity

  2020cites this paper
• Enzymatic degradation of FODMAPS via application of β-fructofuranosidases and α-galactosidases- A fundamental study

  2020cites this paper
• Effects of orally delivered alpha-galactosidase A on gastrointestinal symptoms in patients with Fabry disease.

  2020cites this paper
• Biochemical characterization of a novel protease-resistant α-galactosidase from Paecilomyces thermophila suitable for raffinose family oligosaccharides degradation

  2020cites this paper
• Polysaccharides: bowel health and gut microbiota

  2020cites this paper
• FODMAPs and carbohydrate intolerance

  2020cites this paper
• Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.

  2020cites this paper
• Nutrition Therapy for Intestinal Disorders

  2020cites this paper
• Paediatric functional abdominal pain disorders

  2020cites this paper
• Behavioral and Diet Therapies in Integrated Care for Patients with Irritable Bowel Syndrome.

  2020cites this paper
• Management of Irritable Bowel Syndrome: Physician-Dietitian Collaboration.

  2020cites this paper
• Effect of Ubiquinol Intake on Defecation Frequency and Stool Form: A Prospective, Double-Blinded, Randomized Control Study

  2019cites this paper
• Does Irritable Bowel Syndrome Exist? Identifiable and Treatable Causes of Associated Symptoms Suggest It May Not

  2019cites this paper
• Food Intolerances

  2019cites this paper
• Review article: biological mechanisms for symptom causation by individual FODMAP subgroups ‐ the case for a more personalised approach to dietary restriction

  2019cites this paper
• Reviews of Science for Science Librarians: Low-FODMAP Diets for Irritable Bowel Syndrome and Related Disorders

  2019cites this paper
• Bloating and Abdominal Distention

  2019cites this paper
• Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions

  2018cites this paper
• Update on Dietary Management of Childhood Functional Abdominal Pain Disorders.

  2018cites this paper
• Fermentable short chain carbohydrate (FODMAP) content of common plant‐based foods and processed foods suitable for vegetarian‐ and vegan‐based eating patterns

  2018cites this paper
• The gut microbiome and irritable bowel syndrome

  2018cites this paper
• The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs

  2018cites this paper